Yet another study showed that GPRC5A mRNA levels are higher in HCC patients after 8-week treatment with peretinoin and that the expression of 233 genes including GPRC5A could classify patients into one of two groups, recurrence vs. non-recurrence, with a prediction accuracy rate of 79.6% [8]. Here, GPRC5A is linked to hepatocellular carcinoma.